InvestorsHub Logo
Followers 229
Posts 21457
Boards Moderated 2
Alias Born 08/03/2006

Re: 123tom post# 200251

Tuesday, 10/17/2017 6:25:07 PM

Tuesday, October 17, 2017 6:25:07 PM

Post# of 402589
As for the fundamentals and news for IPIX, I think we're pretty solid for the short term leading into further trial development across the board.

Brilacidin is next up.

And yes, November is a good target and prurisol for December. Tail end of 2017, kevetrin.

Regardless of the fud being posted, $IPIX is still on target for meeting multiple milestones this quarter with an unbeaten track record of 100%. Let's not forget the design of the current set of trials specifically designed to answer the potential for moving forward.


"Tap tap tap", that's big pharma knocking.

$IPIX

Oh yeah, new blog post today.

http://www.ipharminc.com/new-blog/2017/10/17/the-market-opportunity-in-oral-mucositis

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News